Industry Research Reports
Home > Reports > Chemical & Material > Global Acetamide MEA Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Acetamide MEA Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-25
Pages: 128 Pages
Report ld: 5264526
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Acetamide MEA Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 95.5
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 67.8 million
Market Forecast in 2031(Value)
US$ 95.5 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Acetamide MEA market is projected to grow from US$ 65.1 million in 2024 to US$ 95.5 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Acetamide MEA is an aliphatic amide. In cosmetics and personal care products, acetamide MEA functions as a skin conditioning agent – humectant and hair conditioning agent.
The Acetamide MEA (Monoethanolamine) market is experiencing steady growth, primarily driven by its widespread applications in personal care, cosmetics, and industrial formulations. Acetamide MEA is a water-soluble, humectant, and conditioning agent widely used in skincare, hair care, and pharmaceutical products due to its excellent moisturizing and softening properties. The rising demand for mild, non-irritating, and multifunctional ingredients in the cosmetics and personal care sector is a major driver of market expansion. As consumer preferences shift towards skin-friendly and hydrating formulations, Acetamide MEA is gaining traction in products like shampoos, conditioners, lotions, and facial creams. The increasing awareness of clean-label and sulfate-free formulations has further propelled the adoption of Acetamide MEA as an alternative to harsher surfactants and conditioning agents. With the global cosmetics industry expanding rapidly, particularly in regions like North America, Europe, and Asia-Pacific, the demand for mild and effective ingredients continues to rise. Moreover, the natural and sustainable beauty movement is also impacting the market, as manufacturers look for biodegradable and skin-compatible components that align with eco-conscious consumers.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Acetamide MEA market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- The Lubrizol Corporation
- Vantage Specialty Chemicals, Inc
- Universal Preserv-A-Chem Inc. (UPI)
- Croda International Plc
- Alzo International
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 75% Purity
- 100% Purity
- Other
Segment by Application
- Cosmetics
- Personal Care Products
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Acetamide MEA study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Acetamide MEA: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Acetamide MEA Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 75% Purity
1.2.3 100% Purity
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Acetamide MEA Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cosmetics
1.3.3 Personal Care Products
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Acetamide MEA Revenue Estimates and Forecasts 2020-2031
2.2 Global Acetamide MEA Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Acetamide MEA Sales Estimates and Forecasts 2020-2031
2.4 Global Acetamide MEA Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Acetamide MEA Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Acetamide MEA Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Acetamide MEA Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 75% Purity Market Size by Manufacturers
4.5.2 100% Purity Market Size by Manufacturers
4.5.3 Other Market Size by Manufacturers
4.6 Global Acetamide MEA Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Acetamide MEA Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Acetamide MEA Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Acetamide MEA Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Acetamide MEA Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Acetamide MEA Sales and Revenue by Type (2020-2031)
7.4 North America Acetamide MEA Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Acetamide MEA Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Acetamide MEA Sales and Revenue by Type (2020-2031)
8.4 Europe Acetamide MEA Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Acetamide MEA Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Acetamide MEA Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Acetamide MEA Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Acetamide MEA Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Acetamide MEA Sales and Revenue by Type (2020-2031)
10.4 Central and South America Acetamide MEA Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Acetamide MEA Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Acetamide MEA Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Acetamide MEA Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Acetamide MEA Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 The Lubrizol Corporation
12.1.1 The Lubrizol Corporation Corporation Information
12.1.2 The Lubrizol Corporation Business Overview
12.1.3 The Lubrizol Corporation Acetamide MEA Product Models, Descriptions and Specifications
12.1.4 The Lubrizol Corporation Acetamide MEA Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 The Lubrizol Corporation Acetamide MEA Sales by Product in 2024
12.1.6 The Lubrizol Corporation Acetamide MEA Sales by Application in 2024
12.1.7 The Lubrizol Corporation Acetamide MEA Sales by Geographic Area in 2024
12.1.8 The Lubrizol Corporation Acetamide MEA SWOT Analysis
12.1.9 The Lubrizol Corporation Recent Developments
12.2 Vantage Specialty Chemicals, Inc
12.2.1 Vantage Specialty Chemicals, Inc Corporation Information
12.2.2 Vantage Specialty Chemicals, Inc Business Overview
12.2.3 Vantage Specialty Chemicals, Inc Acetamide MEA Product Models, Descriptions and Specifications
12.2.4 Vantage Specialty Chemicals, Inc Acetamide MEA Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Vantage Specialty Chemicals, Inc Acetamide MEA Sales by Product in 2024
12.2.6 Vantage Specialty Chemicals, Inc Acetamide MEA Sales by Application in 2024
12.2.7 Vantage Specialty Chemicals, Inc Acetamide MEA Sales by Geographic Area in 2024
12.2.8 Vantage Specialty Chemicals, Inc Acetamide MEA SWOT Analysis
12.2.9 Vantage Specialty Chemicals, Inc Recent Developments
12.3 Universal Preserv-A-Chem Inc. (UPI)
12.3.1 Universal Preserv-A-Chem Inc. (UPI) Corporation Information
12.3.2 Universal Preserv-A-Chem Inc. (UPI) Business Overview
12.3.3 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA Product Models, Descriptions and Specifications
12.3.4 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA Sales by Product in 2024
12.3.6 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA Sales by Application in 2024
12.3.7 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA Sales by Geographic Area in 2024
12.3.8 Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA SWOT Analysis
12.3.9 Universal Preserv-A-Chem Inc. (UPI) Recent Developments
12.4 Croda International Plc
12.4.1 Croda International Plc Corporation Information
12.4.2 Croda International Plc Business Overview
12.4.3 Croda International Plc Acetamide MEA Product Models, Descriptions and Specifications
12.4.4 Croda International Plc Acetamide MEA Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Croda International Plc Acetamide MEA Sales by Product in 2024
12.4.6 Croda International Plc Acetamide MEA Sales by Application in 2024
12.4.7 Croda International Plc Acetamide MEA Sales by Geographic Area in 2024
12.4.8 Croda International Plc Acetamide MEA SWOT Analysis
12.4.9 Croda International Plc Recent Developments
12.5 Alzo International
12.5.1 Alzo International Corporation Information
12.5.2 Alzo International Business Overview
12.5.3 Alzo International Acetamide MEA Product Models, Descriptions and Specifications
12.5.4 Alzo International Acetamide MEA Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Alzo International Acetamide MEA Sales by Product in 2024
12.5.6 Alzo International Acetamide MEA Sales by Application in 2024
12.5.7 Alzo International Acetamide MEA Sales by Geographic Area in 2024
12.5.8 Alzo International Acetamide MEA SWOT Analysis
12.5.9 Alzo International Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Acetamide MEA Industry Chain
13.2 Acetamide MEA Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Acetamide MEA Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Acetamide MEA Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Acetamide MEA Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Acetamide MEA Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Acetamide MEA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Acetamide MEA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Acetamide MEA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Acetamide MEA Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Acetamide MEA Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Acetamide MEA Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Acetamide MEA Sales by Region (2020-2025) & (Tons)
Table 8. Global Acetamide MEA Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Acetamide MEA Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Acetamide MEA Production by Region (2020-2025) & (Tons)
Table 12. Global Acetamide MEA Production by Region (2026-2031) & (Tons)
Table 13. Global Acetamide MEA Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Acetamide MEA Sales Share by Manufacturers (2020-2025)
Table 15. Global Acetamide MEA Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Acetamide MEA Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Acetamide MEA by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acetamide MEA as of 2024)
Table 19. Global Acetamide MEA Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Acetamide MEA Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Acetamide MEA Manufacturing Base and Headquarters
Table 22. Global Acetamide MEA Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Acetamide MEA Sales by Type (2020-2025) & (Tons)
Table 26. Global Acetamide MEA Sales by Type (2026-2031) & (Tons)
Table 27. Global Acetamide MEA Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Acetamide MEA Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Acetamide MEA ASP by Type (2020-2031) & (US$/kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Acetamide MEA Sales by Application (2020-2025) & (Tons)
Table 32. Global Acetamide MEA Sales by Application (2026-2031) & (Tons)
Table 33. Acetamide MEA High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Acetamide MEA Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Acetamide MEA Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Acetamide MEA ASP by Application (2020-2031) & (US$/kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Acetamide MEA Growth Accelerators and Market Barriers
Table 40. North America Acetamide MEA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Acetamide MEA Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Acetamide MEA Growth Accelerators and Market Barriers
Table 43. Europe Acetamide MEA Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Acetamide MEA Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Acetamide MEA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Acetamide MEA Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Acetamide MEA Growth Accelerators and Market Barriers
Table 48. Southeast Asia Acetamide MEA Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Acetamide MEA Investment Opportunities and Key Challenges
Table 50. Central and South America Acetamide MEA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Acetamide MEA Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Acetamide MEA Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. The Lubrizol Corporation Corporation Information
Table 54. The Lubrizol Corporation Description and Major Businesses
Table 55. The Lubrizol Corporation Product Models, Descriptions and Specifications
Table 56. The Lubrizol Corporation Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 57. The Lubrizol Corporation Sales Value Proportion by Product in 2024
Table 58. The Lubrizol Corporation Sales Value Proportion by Application in 2024
Table 59. The Lubrizol Corporation Sales Value Proportion by Geographic Area in 2024
Table 60. The Lubrizol Corporation Acetamide MEA SWOT Analysis
Table 61. The Lubrizol Corporation Recent Developments
Table 62. Vantage Specialty Chemicals, Inc Corporation Information
Table 63. Vantage Specialty Chemicals, Inc Description and Major Businesses
Table 64. Vantage Specialty Chemicals, Inc Product Models, Descriptions and Specifications
Table 65. Vantage Specialty Chemicals, Inc Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 66. Vantage Specialty Chemicals, Inc Sales Value Proportion by Product in 2024
Table 67. Vantage Specialty Chemicals, Inc Sales Value Proportion by Application in 2024
Table 68. Vantage Specialty Chemicals, Inc Sales Value Proportion by Geographic Area in 2024
Table 69. Vantage Specialty Chemicals, Inc Acetamide MEA SWOT Analysis
Table 70. Vantage Specialty Chemicals, Inc Recent Developments
Table 71. Universal Preserv-A-Chem Inc. (UPI) Corporation Information
Table 72. Universal Preserv-A-Chem Inc. (UPI) Description and Major Businesses
Table 73. Universal Preserv-A-Chem Inc. (UPI) Product Models, Descriptions and Specifications
Table 74. Universal Preserv-A-Chem Inc. (UPI) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Universal Preserv-A-Chem Inc. (UPI) Sales Value Proportion by Product in 2024
Table 76. Universal Preserv-A-Chem Inc. (UPI) Sales Value Proportion by Application in 2024
Table 77. Universal Preserv-A-Chem Inc. (UPI) Sales Value Proportion by Geographic Area in 2024
Table 78. Universal Preserv-A-Chem Inc. (UPI) Acetamide MEA SWOT Analysis
Table 79. Universal Preserv-A-Chem Inc. (UPI) Recent Developments
Table 80. Croda International Plc Corporation Information
Table 81. Croda International Plc Description and Major Businesses
Table 82. Croda International Plc Product Models, Descriptions and Specifications
Table 83. Croda International Plc Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 84. Croda International Plc Sales Value Proportion by Product in 2024
Table 85. Croda International Plc Sales Value Proportion by Application in 2024
Table 86. Croda International Plc Sales Value Proportion by Geographic Area in 2024
Table 87. Croda International Plc Acetamide MEA SWOT Analysis
Table 88. Croda International Plc Recent Developments
Table 89. Alzo International Corporation Information
Table 90. Alzo International Description and Major Businesses
Table 91. Alzo International Product Models, Descriptions and Specifications
Table 92. Alzo International Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Alzo International Sales Value Proportion by Product in 2024
Table 94. Alzo International Sales Value Proportion by Application in 2024
Table 95. Alzo International Sales Value Proportion by Geographic Area in 2024
Table 96. Alzo International Acetamide MEA SWOT Analysis
Table 97. Alzo International Recent Developments
Table 98. Key Raw Materials Distribution
Table 99. Raw Materials Key Suppliers
Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 101. Milestones in Production Technology Evolution
Table 102. Distributors List
Table 103. Market Trends and Market Evolution
Table 104. Market Drivers and Opportunities
Table 105. Market Challenges, Risks, and Restraints
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Acetamide MEA Product Picture
Figure 2. Global Acetamide MEA Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 75% Purity Product Picture
Figure 4. 100% Purity Product Picture
Figure 5. Other Product Picture
Figure 6. Global Acetamide MEA Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Cosmetics
Figure 8. Personal Care Products
Figure 9. Others
Figure 10. Acetamide MEA Report Years Considered
Figure 11. Global Acetamide MEA Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 13. Global Acetamide MEA Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Acetamide MEA Revenue Market Share by Region (2020-2031)
Figure 15. Global Acetamide MEA Sales (2020-2031) & (Tons)
Figure 16. Global Acetamide MEA Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Acetamide MEA Sales Market Share by Region (2020-2031)
Figure 18. Global Acetamide MEA Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Acetamide MEA Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Acetamide MEA Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Acetamide MEA Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Acetamide MEA Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Acetamide MEA Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Acetamide MEA Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Acetamide MEA Sales Volume Market Share in 2024
Figure 27. Global Acetamide MEA Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. 75% Purity Revenue Market Share by Manufacturer in 2024
Figure 30. 100% Purity Revenue Market Share by Manufacturer in 2024
Figure 31. Other Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Acetamide MEA Sales Market Share by Type (2020-2031)
Figure 35. Global Acetamide MEA Revenue Market Share by Type (2020-2031)
Figure 36. Global Acetamide MEA Sales Market Share by Application (2020-2031)
Figure 37. Global Acetamide MEA Revenue Market Share by Application (2020-2031)
Figure 38. North America Acetamide MEA Sales YoY (2020-2031) & (Tons)
Figure 39. North America Acetamide MEA Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Acetamide MEA Sales Revenue (US$ Million) in 2024
Figure 41. North America Acetamide MEA Sales Volume (Tons) by Type (2020- 2031)
Figure 42. North America Acetamide MEA Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Acetamide MEA Sales Volume (Tons) by Application (2020-2031)
Figure 44. North America Acetamide MEA Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Acetamide MEA Sales YoY (2020-2031) & (Tons)
Figure 49. Europe Acetamide MEA Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Acetamide MEA Sales Revenue (US$ Million) in 2024
Figure 51. Europe Acetamide MEA Sales Volume (Tons) by Type (2020-2031)
Figure 52. Europe Acetamide MEA Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Acetamide MEA Sales Volume (Tons) by Application (2020-2031)
Figure 54. Europe Acetamide MEA Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 56. France Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Acetamide MEA Sales YoY (2020-2031) & (Tons)
Figure 61. Asia-Pacific Acetamide MEA Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Acetamide MEA Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Acetamide MEA Sales Volume (Tons) by Type (2020- 2031)
Figure 64. Asia-Pacific Acetamide MEA Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Acetamide MEA Sales Volume (Tons) by Application (2020-2031)
Figure 66. Asia-Pacific Acetamide MEA Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 71. India Acetamide MEA Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Acetamide MEA Sales YoY (2020-2031) & (Tons)
Figure 73. Central and South America Acetamide MEA Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Acetamide MEA Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Acetamide MEA Sales Volume (Tons) by Type (2021-2031)
Figure 76. Central and South America Acetamide MEA Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Acetamide MEA Sales Volume (Tons) by Application (2020-2031)
Figure 78. Central and South America Acetamide MEA Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Acetamide MEA Sales YoY (2020-2031) & (Tons)
Figure 82. Middle East and Africa Acetamide MEA Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Acetamide MEA Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Acetamide MEA Sales Volume (Tons) by Type (2021-2031)
Figure 85. South America Acetamide MEA Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Acetamide MEA Sales Volume (Tons) by Application (2020-2031)
Figure 87. Middle East and Africa Acetamide MEA Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Acetamide MEA Revenue (2020-2025) & (US$ Million)
Figure 92. Acetamide MEA Industry Chain Mapping
Figure 93. Regional Acetamide MEA Manufacturing Base Distribution (%)
Figure 94. Acetamide MEA Production Process
Figure 95. Regional Acetamide MEA Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Acetamide MEA market?
The top companies in the global Acetamide MEA market are The Lubrizol Corporation、Vantage Specialty Chemicals, Inc、Universal Preserv-A-Chem Inc. (UPI).
What was the global market size of Acetamide MEA in 2031?
What is the annual compound growth rate of the global Acetamide MEA market size from 2025 to 2031?
What was the global market size of Acetamide MEA in 2025?
Which region is expected to have the highest market share?
Related Reports
Global Acetamide MEA Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Acetamide MEA market is projected to grow from US$ 67.8 million in 2025 to US$ 101 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 122
USD 4900.00
(Single User License)
Global Acetamide MEA Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Acetamide MEA market size was US$ 67.8 million in 2025 and is forecast to reach a readjusted size of US$ 101 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 71
USD 4250.00
(Single User License)
Acetamide MEA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acetamide MEA was estimated to be worth US$ 67.8 million in 2025 and is projected to reach US$ 101 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 85
USD 3950.00
(Single User License)
Global Acetamide MEA Market Research Report 2026
The global Acetamide MEA market was valued at US$ 67.8 million in 2025 and is anticipated to reach US$ 101 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 118
USD 2900.00
(Single User License)
Acetamide MEA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetamide MEA was estimated to be worth US$ 65.1 million in 2024 and is forecast to a readjusted size of US$ 95.5 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-29
Pages: 90
USD 3950.00
(Single User License)
Global Acetamide MEA Market Insights, Forecast to 2031
The global Acetamide MEA market is projected to grow from US$ 67.8 million in 2025 to US$ 95.5 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published Date: 2025-03-29
Pages: 128
USD 4900.00
(Single User License)
Global Acetamide MEA Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Acetamide MEA market size was US$ 65.1 million in 2024 and is forecast to a readjusted size of US$ 95.5 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-29
Pages: 71
USD 4250.00
(Single User License)
Global Acetamide MEA Market Research Report 2025
The global market for Acetamide MEA was valued at US$ 65.1 million in the year 2024 and is projected to reach a revised size of US$ 95.5 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-03-29
Pages: 76
USD 2900.00
(Single User License)
Acetamide MEA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetamide MEA was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 123
USD 3950.00
(Single User License)
Global Acetamide MEA Market Insights, Forecast to 2030
Acetamide MEA is a type of amide which is synthesized using acetamide and monoethanolamine (MEA). Acetamide MEA is also known as ethanolamine.
Published Date: 2024-04-16
Pages: 90
USD 4900.00
(Single User License)
Global Acetamide MEA Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Acetamide MEA market is projected to grow from US$ 67.8 million in 2025 to US$ 101 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 122
USD 4900.00 (Single User License)Global Acetamide MEA Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Acetamide MEA market size was US$ 67.8 million in 2025 and is forecast to reach a readjusted size of US$ 101 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 71
USD 4250.00 (Single User License)Acetamide MEA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acetamide MEA was estimated to be worth US$ 67.8 million in 2025 and is projected to reach US$ 101 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 85
USD 3950.00 (Single User License)Global Acetamide MEA Market Research Report 2026
The global Acetamide MEA market was valued at US$ 67.8 million in 2025 and is anticipated to reach US$ 101 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 118
USD 2900.00 (Single User License)Acetamide MEA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetamide MEA was estimated to be worth US$ 65.1 million in 2024 and is forecast to a readjusted size of US$ 95.5 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-29
Pages: 90
USD 3950.00 (Single User License)Global Acetamide MEA Market Insights, Forecast to 2031
The global Acetamide MEA market is projected to grow from US$ 67.8 million in 2025 to US$ 95.5 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published: 2025-03-29
Pages: 128
USD 4900.00 (Single User License)Global Acetamide MEA Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Acetamide MEA market size was US$ 65.1 million in 2024 and is forecast to a readjusted size of US$ 95.5 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-29
Pages: 71
USD 4250.00 (Single User License)Global Acetamide MEA Market Research Report 2025
The global market for Acetamide MEA was valued at US$ 65.1 million in the year 2024 and is projected to reach a revised size of US$ 95.5 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-03-29
Pages: 76
USD 2900.00 (Single User License)Acetamide MEA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetamide MEA was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 123
USD 3950.00 (Single User License)Global Acetamide MEA Market Insights, Forecast to 2030
Acetamide MEA is a type of amide which is synthesized using acetamide and monoethanolamine (MEA). Acetamide MEA is also known as ethanolamine.
Published: 2024-04-16
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now